Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03087838
Other study ID # KY2017-018-02
Secondary ID
Status Completed
Phase N/A
First received March 17, 2017
Last updated February 8, 2018
Start date March 1, 2017
Est. completion date February 2, 2018

Study information

Verified date February 2018
Source Capital Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Postoperative delirium may result in many adverse complications. At present little is known about postoperative delirium in patients after crniotomy because they may manifest similar symptoms to definitely delirium for some structural brain disease. Objective of this study is to find out incidence and risk factors of postoperative delirium in patients after elective craniotomy and also the relationship of postoperative delirium with clinical outcome.


Description:

The study is a prospective single-center cohort study. Consecutive adult patients admitted to the ICU after elective craniotomy is enrolled. Richmond Agitation Sedation Scale (RASS) is used to assess level of consciousness of patients; if conditions met "RASSā‰„-3", the Confusion Assessment Method for the Intensive Care Unit will proceed to evaluate delirium signs in patients. Delirium is assessed every 12-hour shift within 3 days during the patient's ICU stay and ended when discharged from ICU or dead, time started at 9am and 9pm. On the third day after operation when most patients have been transferred to general ward, delirium was assessed only at 9am for follow-up studies. Patients is divided into two groups via assessment of CAM-ICU: delirium groups and non-delirium groups. Factors potentially related to postoperative delirium are collected and categorized as preoperative, intraoperative and postoperative in chronological order. Univariate analyses between delirium groups and non-delirium groups is performed. The stepwise backward logistic regression is carried out to identify the independent predictors of delirium. Patients will be followed up until hospital discharge, death or 90 days after the enrollment. Clinical outcome such as days on the mechanical ventilator, endotracheal extubation time, need for re-intubation and tracheotomy, unexpected reoperation within 72 h after surgery, length of stay in the ICU , hospital costs and mortality will be registered.


Recruitment information / eligibility

Status Completed
Enrollment 800
Est. completion date February 2, 2018
Est. primary completion date November 1, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients after elective craniotomy under general anaesthesia and admitted to the ICU directly after surgery.

Exclusion Criteria:

1. Patients younger than 18 years

2. Patients with emergency operation

3. Patients with preoperative impairment of consciousness (GCS<8)

4. Patients with a past medical history of delirium or schizophrenia(evaluated by the medical document)

5. Patients withventriculoperitoneal shunt or endoscope operation

6. Patients with inability to communicate in the preoperative period(including language barrier)

7. Pregnant or lactating women.

Study Design


Locations

Country Name City State
China ICU, Beijing Tiantan Hospital, Capital Medical University Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Capital Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative delirium CAM-ICU is positive Within the first 24 hours after operation
See also
  Status Clinical Trial Phase
Completed NCT00487097 - The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients N/A
Completed NCT01997931 - The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients N/A
Recruiting NCT04926220 - Dynamic Estimation of Cardiac Output in the Operating Room
Not yet recruiting NCT03617796 - Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
Withdrawn NCT04554264 - Complicated Grief in ICU in the Aftermath of COVID-19 N/A
Recruiting NCT02587273 - The Pharmacokinetics of Fentanyl in Intensive Care Patients Phase 4
Withdrawn NCT01749488 - The Impact of a Dietitian in the Implementation of Nutrition Recommendations During Intensive Care N/A
Recruiting NCT06110390 - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients N/A
Completed NCT04186611 - Early Occupational Therapy in Intensive Care: Feasibility of Implementation N/A
Completed NCT03299894 - Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department N/A
Recruiting NCT03777150 - Is There a Benefit of Postoperative ICU Management After Elective Surgery in Critical Ill Patients? N/A
Completed NCT02583321 - Detection of Chlorhexidine in Tracheal Secretions After Routine Oral Care With Chlorhexidine Gluconate N/A
Completed NCT00787098 - Investigating Modes of Progressive Mobility Phase 2
Recruiting NCT04114747 - Renal Physiology During Continuous Renal Replacement Therapy N/A
Completed NCT02476591 - Charge Transparency in Critical Care Practice and Its Effects on Overall Cost of Care N/A
Completed NCT05795777 - Examination of the Pressure Ulcers in Intensive Care Patients.
Terminated NCT02587130 - Ketamine and Refractory Painful Care in a Palliative Unit Phase 4
Completed NCT02463123 - Energy Expenditure Estimation in Cardiac Surgery N/A
Completed NCT01607723 - "NAVA-PAV" Study: a Cross-over Comparative Study of 2 Advanced Modes Phase 3
Completed NCT01346813 - Epidemiology of Painful Procedures in Neonates N/A